XB-IMG-144998
Xenbase Image ID: 144998
|
Fig. 6. Whole-mount in situ analyses of embryos stained for
expression of XNkx2-5, or XNkx2-5 and XcTnI. Embryos were
injected with a total of 200 pg of DNA into one cell at the twocell
stage, fixed, and processed for whole-mount in situ
analyses staining for XNkx2-5 mRNA alone, or for both
XNkx2-5 and XcTnI mRNAs utilizing double-label in situ (see
Materials and Methods for details). XNkx2-5 mRNA signal
was detected utilizing BCIP/NBT (brownish-purple color),
and XcTnI mRNA signal was detected utilizing BCIP alone
(light blue color). Overlap of the two signals gives a dark blue
signal (E and F). Anterior is to the right. The mutant embryos
shown were coinjected with both EnHDX2.3 and EnHDX2.5.
(A) Control-injected stage 21 embryo, ventral view, showing
symmetrical XNkx2-5 mRNA staining just posterior to the
cement gland. (B) EnHD-injected stage 21 embryo, ventral
view, with arrow indicating reduction in XNkx2-5 mRNA
staining relative to the other side of the embryo. (C) Control
injected stage 24 embryo, ventral view, showing XNkx2-5
mRNA in fused cardiac primordia posterior to the cement
gland. (D). EnHD-injected stage 24 embryo, ventral view, with
arrow indicating absence of XNkx2-5 mRNA staining on one
side of the embryo. (E) Control injected stage 32 embryo,
ventrolateral view, co-stained for XNkx2-5 and XcTnI mRNAs
(dark blue). (F) EnHD-injected stage 33 embryo, ventrolateral
view, co-stained for XNkx2-5 and XcTnI mRNAs. In this
embryo, the positively staining regions have not yet fused.
Although one side stains positively for both XNkx2-5 and
XcTnI mRNAs (dark blue staining as indicated by blue
arrowhead), the other side shows very faint staining for both
mRNAs (black arrow). C, cement gland. Image published in: Fu Y et al. (1998) Copyright © 1998. Image reproduced with permission of the publisher and the copyright holder. This is an Open Access article distributed under the terms of the Creative Commons Attribution License.
Image source: Published Larger Image Printer Friendly View |